279 related articles for article (PubMed ID: 12904862)
1. Cyclic nucleotide phosphodiesterases in pancreatic islets.
Pyne NJ; Furman BL
Diabetologia; 2003 Sep; 46(9):1179-89. PubMed ID: 12904862
[TBL] [Abstract][Full Text] [Related]
2. The calcium/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion.
Han P; Werber J; Surana M; Fleischer N; Michaeli T
J Biol Chem; 1999 Aug; 274(32):22337-44. PubMed ID: 10428803
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphodiesterases in the shaping of sub-plasma-membrane cAMP oscillations and pulsatile insulin secretion.
Tian G; Sågetorp J; Xu Y; Shuai H; Degerman E; Tengholm A
J Cell Sci; 2012 Nov; 125(Pt 21):5084-95. PubMed ID: 22946044
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
5. Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11.
Ahmad M; Abdel-Wahab YH; Tate R; Flatt PR; Pyne NJ; Furman BL
Br J Pharmacol; 2000 Mar; 129(6):1228-34. PubMed ID: 10725272
[TBL] [Abstract][Full Text] [Related]
6. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
7. The role of the cyclic GMP-inhibited cyclic AMP-specific phosphodiesterase (PDE3) in regulating clonal BRIN-BD11 insulin secreting cell survival.
Ahmad M; Flatt PR; Furman BL; Pyne NJ
Cell Signal; 2000 Aug; 12(8):541-8. PubMed ID: 11027947
[TBL] [Abstract][Full Text] [Related]
8. [Phosphodiesterases of cyclic GMP].
Wróblewska H; Gorczyca WA
Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
Netherton SJ; Maurice DH
Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
[TBL] [Abstract][Full Text] [Related]
11. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
[TBL] [Abstract][Full Text] [Related]
12. Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin.
Härndahl L; Jing XJ; Ivarsson R; Degerman E; Ahrén B; Manganiello VC; Renström E; Holst LS
J Biol Chem; 2002 Oct; 277(40):37446-55. PubMed ID: 12169692
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic β-cells.
Pratt EPS; Harvey KE; Salyer AE; Hockerman GH
PLoS One; 2019; 14(8):e0215188. PubMed ID: 31442224
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
Liu H; Maurice DH
Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of cyclic nucleotide phosphodiesterase isozymes during culture of aortic endothelial cells.
Ashikaga T; Strada SJ; Thompson WJ
Biochem Pharmacol; 1997 Nov; 54(10):1071-9. PubMed ID: 9464449
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.
Tetsi L; Charles AL; Paradis S; Lejay A; Talha S; Geny B; Lugnier C
Cell Mol Life Sci; 2017 May; 74(10):1883-1893. PubMed ID: 28039524
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells.
Ahmad F; Cong LN; Stenson Holst L; Wang LM; Rahn Landstrom T; Pierce JH; Quon MJ; Degerman E; Manganiello VC
J Immunol; 2000 May; 164(9):4678-88. PubMed ID: 10779773
[TBL] [Abstract][Full Text] [Related]
19. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G
Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978
[TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system.
Maurice DH
Front Biosci; 2005 May; 10():1221-8. PubMed ID: 15769620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]